Lockdown an opportunity for resetting agenda in financial market reforms: Mark Matthews, Julius Baer

The real economic problem of India, according to him, is that the country's financial system continues to be weighed down by issues like under capitalisation of state-owned banks as well as the "lending scandals" in the private banks and non-banking financial companies (NBFCs).

Moneycontrol News

April 02, 2020 / 08:19 PM IST

The novel coronavirus outbreak has battered markets worldwide and it will be sometime before investor sentiment is back to normal.

Amid the ongoing efforts across the globe to contain the spread of the COVID-19, Prime Minister Narendra Modi on March 24 announced a 21-day nationwide lockdown.

This could very well be used as an opportunity to reset the agenda for the financial market reforms in the country, says Mark Matthews, Head of Research-Asia, Julius Baer.

Track this blog for all the latest updates on the coronavirus outbreak

"While the 21-day lockdown in India has caused much distress, especially in the migrant worker community, it is also a time for a reset of financial market reforms," he said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show